Huons Global Co., Ltd. (084110.KQ)
KRW 46750.0
(-0.53%)
KRW 46750.0
(-0.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 254.93 Billion KRW | -11.96% |
| 2022 | 289.55 Billion KRW | 15.61% |
| 2021 | 250.44 Billion KRW | 30.24% |
| 2020 | 192.29 Billion KRW | 147.25% |
| 2019 | 77.77 Billion KRW | 19.12% |
| 2018 | 65.29 Billion KRW | 7.61% |
| 2017 | 60.67 Billion KRW | 9.26% |
| 2016 | 55.53 Billion KRW | 68.27% |
| 2015 | 33 Billion KRW | -9.71% |
| 2014 | 36.55 Billion KRW | -30.96% |
| 2013 | 52.94 Billion KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 262.88 Billion KRW | 8.5% |
| 2024 Q1 | 242.29 Billion KRW | -4.96% |
| 2023 FY | 254.93 Billion KRW | -11.96% |
| 2023 Q3 | 251.08 Billion KRW | 3.92% |
| 2023 Q2 | 241.6 Billion KRW | -6.62% |
| 2023 Q1 | 258.73 Billion KRW | -10.64% |
| 2023 Q4 | 254.93 Billion KRW | 1.53% |
| 2022 Q4 | 289.55 Billion KRW | 1.64% |
| 2022 Q1 | 261.37 Billion KRW | 4.36% |
| 2022 Q2 | 288.39 Billion KRW | 10.34% |
| 2022 Q3 | 284.87 Billion KRW | -1.22% |
| 2022 FY | 289.55 Billion KRW | 15.61% |
| 2021 Q1 | 204.82 Billion KRW | 7.54% |
| 2021 Q2 | 244.73 Billion KRW | 19.49% |
| 2021 Q3 | 220.42 Billion KRW | -9.93% |
| 2021 Q4 | 250.44 Billion KRW | 13.62% |
| 2021 FY | 250.44 Billion KRW | 30.24% |
| 2020 FY | 192.29 Billion KRW | 147.25% |
| 2020 Q1 | 74.24 Billion KRW | -2.66% |
| 2020 Q3 | 163.4 Billion KRW | -0.73% |
| 2020 Q4 | 190.46 Billion KRW | 16.56% |
| 2020 Q2 | 164.6 Billion KRW | 121.7% |
| 2019 FY | 77.77 Billion KRW | 19.12% |
| 2019 Q2 | 67.96 Billion KRW | -1.55% |
| 2019 Q4 | 76.27 Billion KRW | 6.86% |
| 2019 Q1 | 69.04 Billion KRW | 5.74% |
| 2019 Q3 | 71.37 Billion KRW | 5.01% |
| 2018 Q2 | 62.58 Billion KRW | -0.53% |
| 2018 Q4 | 65.29 Billion KRW | 17.44% |
| 2018 Q3 | 55.59 Billion KRW | -11.17% |
| 2018 Q1 | 62.91 Billion KRW | 3.97% |
| 2018 FY | 65.29 Billion KRW | 7.61% |
| 2017 Q1 | 61.07 Billion KRW | 9.99% |
| 2017 Q2 | 57.5 Billion KRW | -5.84% |
| 2017 Q3 | 62.72 Billion KRW | 9.08% |
| 2017 FY | 60.67 Billion KRW | 9.26% |
| 2017 Q4 | 60.51 Billion KRW | -3.53% |
| 2016 Q1 | 11.17 Billion KRW | -66.13% |
| 2016 FY | 55.53 Billion KRW | 68.27% |
| 2016 Q4 | 55.53 Billion KRW | 5.74% |
| 2016 Q3 | 52.51 Billion KRW | 411.69% |
| 2016 Q2 | 10.26 Billion KRW | -8.18% |
| 2015 FY | 33 Billion KRW | -9.71% |
| 2015 Q4 | 33 Billion KRW | -4.15% |
| 2015 Q3 | 34.42 Billion KRW | 13.74% |
| 2015 Q2 | 30.27 Billion KRW | -10.91% |
| 2015 Q1 | 33.97 Billion KRW | -7.05% |
| 2014 Q1 | 51.46 Billion KRW | -2.8% |
| 2014 FY | 36.55 Billion KRW | -30.96% |
| 2014 Q3 | 38.86 Billion KRW | -8.41% |
| 2014 Q4 | 36.55 Billion KRW | -5.95% |
| 2014 Q2 | 42.43 Billion KRW | -17.54% |
| 2013 Q2 | 59.5 Billion KRW | -7.06% |
| 2013 Q1 | 64.02 Billion KRW | 0.0% |
| 2013 Q4 | 52.94 Billion KRW | -6.66% |
| 2013 Q3 | 56.71 Billion KRW | -4.69% |
| 2013 FY | 52.94 Billion KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 23.72 Billion KRW | -974.422% |
| CMG Pharmaceutical Co., Ltd. | 19.74 Billion KRW | -1191.252% |
| Celltrion Pharm, Inc. | 162.52 Billion KRW | -56.857% |
| DongKook Pharmaceutical Co., Ltd. | 104.74 Billion KRW | -143.382% |
| Enzychem Lifesciences Corporation | 5.65 Billion KRW | -4406.558% |
| Humedix Co., Ltd. | 2.7 Billion KRW | -9335.961% |
| Boditech Med Inc. | 10.56 Billion KRW | -2312.369% |
| EuBiologics Co., Ltd. | 14.77 Billion KRW | -1625.013% |
| FutureChem Co.,Ltd | 3.68 Billion KRW | -6822.82% |
| Huons Co., Ltd. | 124.61 Billion KRW | -104.585% |
| BNC Korea Co., Ltd. | 737.2 Million KRW | -34481.333% |
| AptaBio Therapeutics Inc. | 13.93 Billion KRW | -1729.587% |